Gan & Lee Pharmaceuticals Co Ltd (603087) — Cash Flow Quality Index
Gan & Lee Pharmaceuticals Co Ltd (603087) has a Cash Flow Quality Index of 1.20x as of September 2025. Operating cash flow of CN¥257.27 Million exceeds net income of CN¥214.66 Million, indicating high earnings quality where cash backs reported profits. Also explore Gan & Lee Pharmaceuticals Co Ltd asset portfolio for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Gan & Lee Pharmaceuticals Co Ltd Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for Gan & Lee Pharmaceuticals Co Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Gan & Lee Pharmaceuticals Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Gan & Lee Pharmaceuticals Co Ltd (2013–2025)
Year-by-year earnings quality comparison for Gan & Lee Pharmaceuticals Co Ltd. For live market cap and the full company financial profile, see 603087 market cap overview.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.69x | CN¥784.28 Million | CN¥1.14 Billion | ▼ -21.5% |
| 2024 | 0.87x | CN¥537.31 Million | CN¥614.66 Million | ▼ -30.5% |
| 2023 | 1.26x | CN¥427.69 Million | CN¥340.07 Million | ▲ +69.5% |
| 2021 | 0.74x | CN¥1.08 Billion | CN¥1.45 Billion | ▼ -26.4% |
| 2020 | 1.01x | CN¥1.24 Billion | CN¥1.23 Billion | ▲ +2.0% |
| 2019 | 0.99x | CN¥1.15 Billion | CN¥1.17 Billion | ▲ +120.9% |
| 2018 | 0.45x | CN¥418.04 Million | CN¥933.97 Million | ▼ -49.1% |
| 2017 | 0.88x | CN¥949.60 Million | CN¥1.08 Billion | ▼ -12.1% |
| 2016 | 1.00x | CN¥769.63 Million | CN¥769.63 Million | ▲ +0.0% |
| 2015 | 1.00x | CN¥447.42 Million | CN¥447.42 Million | ▲ +0.0% |
| 2014 | 1.00x | CN¥305.22 Million | CN¥305.22 Million | ▲ +0.0% |
| 2013 | 1.00x | CN¥204.73 Million | CN¥204.73 Million | — |